SC 13G/A: Alkermes plc.
Ticker: ALKS · Form: SC 13G/A · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Alkermes plc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0000932471-24-000871 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000932471-24-000871 Filing Date 2024-11-12 Accepted 2024-11-12 13:28:21 Documents 1 Document Format Files Seq Description Document Type Size 1 UnitedStates_13G__AlkermesPL.txt SC 13G/A 4991 Complete submission text file 0000932471-24-000871.txt 6724 Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000 VANGUARD GROUP INC (Filed by) CIK : 0000102909 (see all company filings) EIN. : 231945930 | State of Incorp.: PA | Fiscal Year End: 1231 Type: SC 13G/A Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000 Alkermes plc. (Subject) CIK : 0001520262 (see all company filings) EIN. : 981007018 | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-86627 | Film No.: 241446526 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)